Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CCND2 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → CCND2 |
| (<<) HLA-DOA → CCND2 |
| (<<) INPP5D → CCND2 |
| (<<) JAK3 → CCND2 |
| (<<) LPXN → CCND2 |
| (<<) LTB → CCND2 |
| (<<) NR3C1 → CCND2 |
| (<<) PIK3CD → CCND2 |
| (<<) PTGER4 → CCND2 |
| (<<) RASSF5 → CCND2 |
| (<<) TUBB2C → CCND2 |
| Downstream (Children) |
|---|
| CCND2 → ADAM19 (>>) |
| CCND2 → ANGPTL4 (>>) |
| CCND2 → AXL (>>) |
| CCND2 → BCL2 (>>) |
| CCND2 → BLNK (>>) |
| CCND2 → CASP1 (>>) |
| CCND2 → CASP10 (>>) |
| CCND2 → CAV1 (>>) |
| CCND2 → CCNB2 (>>) |
| CCND2 → CLEC2B (>>) |
| CCND2 → DUSP5 (>>) |
| CCND2 → GBP2 (>>) |
| CCND2 → GNB2L1 (>>) |
| CCND2 → HOPX (>>) |
| CCND2 → HSPC159 (>>) |
| CCND2 → ITGB6 (>>) |
| CCND2 → KCTD12 (>>) |
| CCND2 → KHDRBS1 (>>) |
| CCND2 → LCP1 (>>) |
| CCND2 → MAL (>>) |
| CCND2 → NGEF (>>) |
| CCND2 → PAG1 (>>) |
| CCND2 → PTK2 (>>) |
| CCND2 → PTPRE (>>) |
| CCND2 → STK17A (>>) |
| CCND2 → STK17B (>>) |
| CCND2 → SYK (>>) |
| CCND2 → TCF4 (>>) |
| CCND2 → TRERF1 (>>) |
